|
1
|
Howard EW, Leung SC, Yuen HF, Chua CW, Lee
DT, Chan KW, Wang X and Wong YC: Decreased adhesiveness, resistance
to anoikis and suppression of GRP94 are integral to the survival of
circulating tumor cells in prostate cancer. Clin Exp Metastasis.
25:497–508. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Khongmanee A, Lirdprapamongkol K, Tit-oon
P, Chokchaichamnankit D, Svasti J and Srisomsap C: Proteomic
analysis reveals important role of 14-3-3σ in anoikis resistance of
cholangiocarcinoma cells. Proteomics. 13:3157–3166. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim JB, Yu JH, Ko E, Lee KW, Song AK, Park
SY, Shin I, Han W and Noh DY: The alkaloid Berberine inhibits the
growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell
lines by inducing cell cycle arrest. Phytomedicine. 17:436–440.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mori S, Chang JT, Andrechek ER, Matsumura
N, Baba T, Yao G, Kim JW, Gatza M, Murphy S and Nevins JR:
Anchorage-independent cell growth signature identifies tumors with
metastatic potential. Oncogene. 28:2796–2805. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hart GW, Housley MP and Slawson C: Cycling
of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins.
Nature. 446:1017–1022. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kreppel LK, Blomberg MA and Hart GW:
Dynamic glycosylation of nuclear and cytosolic proteins. Cloning
and characterization of a unique O-GlcNAc transferase with
multiple tetratricopeptide repeats. J Biol Chem. 272:9308–9315.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gao Y, Wells L, Comer FI, Parker GJ and
Hart GW: Dynamic O-glycosylation of nuclear and cytosolic proteins:
Cloning and characterization of a neutral, cytosolic
beta-N-acetylglucosaminidase from human brain. J Biol Chem.
276:9838–9845. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma Z and Vosseller K: O-GlcNAc in
cancer biology. Amino Acids. 45:719–733. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fardini Y, Dehennaut V, Lefebvre T and
Issad T: O-GlcNAcylation: A New Cancer Hallmark? Front
Endocrinol (Lausanne). 4:992013.PubMed/NCBI
|
|
10
|
Chaiyawat P, Netsirisawan P, Svasti J and
Champattanachai V: Aberrant O-GlcNAcylated proteins: New
perspectives in breast and colorectal cancer. Front Endocrinol
(Lausanne). 5:1932014.PubMed/NCBI
|
|
11
|
Champattanachai V, Netsirisawan P,
Chaiyawat P, Phueaouan T, Charoenwattanasatien R,
Chokchaichamnankit D, Punyarit P, Srisomsap C and Svasti J:
Proteomic analysis and abrogated expression of
O-GlcNAcylated proteins associated with primary breast
cancer. Proteomics. 13:2088–2099. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Phueaouan T, Chaiyawat P, Netsirisawan P,
Chokchaichamnankit D, Punyarit P, Srisomsap C, Svasti J and
Champattanachai V: Aberrant O-GlcNAc-modified proteins
expressed in primary colorectal cancer. Oncol Rep. 30:2929–2936.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chaiyawat P, Chokchaichamnankit D,
Lirdprapamongkol K, Srisomsap C, Svasti J and Champattanachai V:
Alteration of O-GlcNAcylation affects serine phosphorylation
and regulates gene expression and activity of pyruvate kinase M2 in
colorectal cancer cells. Oncol Rep. 34:1933–1942. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chiablaem K, Lirdprapamongkol K,
Keeratichamroen S, Surarit R and Svasti J: Curcumin suppresses
vasculogenic mimicry capacity of hepatocellular carcinoma cells
through STAT3 and PI3K/AKT inhibition. Anticancer Res.
34:1857–1864. 2014.PubMed/NCBI
|
|
15
|
Caldwell SA, Jackson SR, Shahriari KS,
Lynch TP, Sethi G, Walker S, Vosseller K and Reginato MJ: Nutrient
sensor O-GlcNAc transferase regulates breast cancer
tumorigenesis through targeting of the oncogenic transcription
factor FoxM1. Oncogene. 29:2831–2842. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Steenackers A, Olivier-Van Stichelen S,
Baldini SF, Dehennaut V, Toillon RA, Le Bourhis X, El
Yazidi-Belkoura I and Lefebvre T: Silencing the nucleocytoplasmic
O-GlcNAc transferase reduces proliferation, adhesion, and
migration of cancer and fetal human colon cell lines. Front
Endocrinol (Lausanne). 7:462016.PubMed/NCBI
|
|
17
|
Mi W, Gu Y, Han C, Liu H, Fan Q, Zhang X,
Cong Q and Yu W: O-GlcNAcylation is a novel regulator of
lung and colon cancer malignancy. Biochim Biophys Acta.
1812:514–519. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang X, Qiao Y, Wu Q, Chen Y, Zou S, Liu
X, Zhu G, Zhao Y, Chen Y, Yu Y, et al: The essential role of YAP
O-GlcNAcylation in high-glucose-stimulated liver
tumorigenesis. Nat Commun. 8:152802017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu Q, Tao T, Liu F, Ni R, Lu C and Shen
A: Hyper-O-GlcNAcylation of YB-1 affects Ser102
phosphorylation and promotes cell proliferation in hepatocellular
carcinoma. Exp Cell Res. 349:230–238. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu G, Tao T, Zhang D, Liu X, Qiu H, Han
L, Xu Z, Xiao Y, Cheng C and Shen A: O-GlcNAcylation of
histone deacetylases 1 in hepatocellular carcinoma promotes cancer
progression. Glycobiology. 26:820–833. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Itkonen HM, Gorad SS, Duveau DY, Martin
SE, Barkovskaya A, Bathen TF, Moestue SA and Mills IG: Inhibition
of O-GlcNAc transferase activity reprograms prostate cancer
cell metabolism. Oncotarget. 7:12464–12476. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gu Y, Gao J, Han C, Zhang X, Liu H, Ma L,
Sun X and Yu W: O-GlcNAcylation is increased in prostate
cancer tissues and enhances malignancy of prostate cancer cells.
Mol Med Rep. 10:897–904. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang X and Qian K: Protein
O-GlcNAcylation: Emerging mechanisms and functions. Nat Rev
Mol Cell Biol. 18:452–465. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
O'Donnell N, Zachara NE, Hart GW and Marth
JD: Ogt-dependent X-chromosome-linked protein glycosylation is a
requisite modification in somatic cell function and embryo
viability. Mol Cell Biol. 24:1680–1690. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zachara NE, O'Donnell N, Cheung WD, Mercer
JJ, Marth JD and Hart GW: Dynamic O-GlcNAc modification of
nucleocytoplasmic proteins in response to stress. A survival
response of mammalian cells. J Biol Chem. 279:30133–30142. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gu Y, Mi W, Ge Y, Liu H, Fan Q, Han C,
Yang J, Han F, Lu X and Yu W: GlcNAcylation plays an essential role
in breast cancer metastasis. Cancer Res. 70:6344–6351. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma Z, Vocadlo DJ and Vosseller K:
Hyper-O-GlcNAcylation is anti-apoptotic and maintains
constitutive NF-κB activity in pancreatic cancer cells. J Biol
Chem. 288:15121–15130. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Arrigo AP and Gibert B: HspB1, HspB5 and
HspB4 in human cancers: Potent oncogenic role of some of their
client proteins. Cancers (Basel). 6:333–365. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hung CS, Huang CY, Lee CH, Chen WY, Huang
MT, Wei PL and Chang YJ: IGFBP2 plays an important role in heat
shock protein 27-mediated cancer progression and metastasis.
Oncotarget. 8:54978–54992. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cordonnier T, Bishop JL, Shiota M, Nip KM,
Thaper D, Vahid S, Heroux D, Gleave M and Zoubeidi A: Hsp27
regulates EGF/β-catenin mediated epithelial to mesenchymal
transition in prostate cancer. Int J Cancer. 136:E496–E507. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gibert B, Eckel B, Gonin V, Goldschneider
D, Fombonne J, Deux B, Mehlen P, Arrigo AP, Clézardin P and
Diaz-Latoud C: Targeting heat shock protein 27 (HspB1) interferes
with bone metastasis and tumour formation in vivo. Br J Cancer.
107:63–70. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Choi SH, Nam JK, Kim BY, Jang J, Jin YB,
Lee HJ, Park S, Ji YH, Cho J and Lee YJ: HSPB1 inhibits the
endothelial-to-mesenchymal transition to suppress pulmonary
fibrosis and lung tumorigenesis. Cancer Res. 76:1019–1030. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lee YJ, Lee HJ, Choi SH, Jin YB, An HJ,
Kang JH, Yoon SS and Lee YS: Soluble HSPB1 regulates VEGF-mediated
angiogenesis through their direct interaction. Angiogenesis.
15:229–242. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang G, Gu X, Chen L, Wang Y and Cao B; E
Q, : Comparison of the expression of 5 heat shock proteins in
benign and malignant salivary gland tumor tissues. Oncol Lett.
5:1363–1369. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mo XM, Li L, Zhu P, Dai YJ, Zhao TT, Liao
LY, Chen GG and Liu ZM: Up-regulation of Hsp27 by ERα/Sp1
facilitates proliferation and confers resistance to apoptosis in
human papillary thyroid cancer cells. Mol Cell Endocrinol.
431:71–87. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang X, Su K, Roos MD, Chang Q, Paterson
AJ and Kudlow JE: O-linkage of N-acetylglucosamine to Sp1
activation domain inhibits its transcriptional capability. Proc
Natl Acad Sci USA. 98:6611–6616. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guo K, Gan L, Zhang S, Cui FJ, Cun W, Li
Y, Kang NX, Gao MD and Liu KY: Translocation of HSP27 into liver
cancer cell nucleus may be associated with phosphorylation and
O-GlcNAc glycosylation. Oncol Rep. 28:494–500. 2012.
View Article : Google Scholar : PubMed/NCBI
|
